CTGF/CCN2 activates canonical Wnt signalling in mesangial cells through LRP6: Implications for the pathogenesis of diabetic nephropathy

Wnt/β-catenin signaling: A novel target for therapeutic intervention of fibrotic kidney disease

(2010) Inah Hwang et al.   ARCHIVES OF PHARMACAL RESEARCH

Inhibition of Connective Tissue Growth Factor Overexpression in Diabetic Retinopathy by SERPINA3K via Blocking the WNT/ -Catenin Pathway

(2010) B. Zhang et al.   DIABETES

Dickkopf-1 Promotes Hyperglycemia-Induced Accumulation of Mesangial Matrix and Renal Dysfunction

(2009) C.-L. Lin et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Wnt/ -Catenin Signaling Promotes Podocyte Dysfunction and Albuminuria

(2009) C. Dai et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Wnt/ -Catenin Signaling Promotes Renal Interstitial Fibrosis

(2009) W. He et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Wnt 10b activates the CCN2 promoter in NIH 3T3 fibroblasts through the Smad response element

(2009) Shaoqiong Chen et al.   Journal of Cell Communication and Signaling

Glucose induces an autocrine activation of the Wnt/β-catenin pathway in macrophage cell lines

(2008) Sasha H. Anagnostou et al.   BIOCHEMICAL JOURNAL

Regulation and consequences of differential gene expression in diabetic kidney disease: Figure 1

(2008) Madeline Murphy et al.   BIOCHEMICAL SOCIETY TRANSACTIONS

Skeletal Overexpression of Connective Tissue Growth Factor Impairs Bone Formation and Causes Osteopenia

(2008) Anna Smerdel-Ramoya et al.   ENDOCRINOLOGY

Connective Tissue Growth Factor Enhances Osteoblastogenesisin Vitro

(2008) Anna Smerdel-Ramoya et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Unraveling the role of connective tissue growth factor in diabetic nephropathy

(2008) K.M. Schmidt-Ott   KIDNEY INTERNATIONAL